 | • レポートコード：D0GIR-01277 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、103ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、mRNA療法の世界市場を広く調査・分析し、今後の市場展望をまとめております。mRNA療法の種類別市場規模（ワクチン、医薬品）、用途別市場規模（生体内mRNAターゲットデリバリー、遺伝子組み換えT細胞、癌免疫療法開発ナノ粒子形質転換、小分子薬発見）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Moderna、Arcturus Therapeutics Holdings Inc.、BioNTech、Pfizer、CureVac、Astrazeneca ・地域別グローバル市場分析 2015年-2020年 ・mRNA療法の北米市場（アメリカ、カナダ、メキシコ） ・mRNA療法のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・mRNA療法のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・mRNA療法の南米市場（ブラジル、アルゼンチン） ・mRNA療法の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ワクチン、医薬品 ・用途別分析：生体内mRNAターゲットデリバリー、遺伝子組み換えT細胞、癌免疫療法開発ナノ粒子形質転換、小分子薬発見 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The mRNA Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The most likely (base case) scenario is that the global mRNA Therapy sales will be xx in 2020 from mRNA Therapy million in 2019, with a change xx% between 2019 and 2020. In addition, based on the latest study, it is to predict that the Covid-19 will be under control in key countries like the United States, Western Europe, East Asia, by the end of Q2 (June), and will resume normal production in Q3 and Q4, the global mRNA Therapy market size is expected to grow at xx% or more annually for the next five years.
This report also researches and evaluates the impact of Covid-19 outbreak on the mRNA Therapy industry, involving potential opportunity and challenges, drivers and risks. We present the impact assessment of Covid-19 effects on mRNA Therapy and market growth forecast based on different scenario (optimistic, pessimistic, very optimistic, most likely etc.).
Market segmentation
mRNA Therapy market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, mRNA Therapy market has been segmented into:
Vaccine
Drugs
By Application, mRNA Therapy has been segmented into:
mRNA Targeted Delivery in vivo
Genetically Modified T cells
Transforming Nanoparticles to Develop Immunotherapy for Cancer
Small Molecule Drugs Discovery
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global mRNA Therapy market presented in the report. This section sheds light on the sales growth of different regional and country-level mRNA Therapy markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global mRNA Therapy market.
The report offers in-depth assessment of the growth and other aspects of the mRNA Therapy market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and mRNA Therapy Market Share Analysis
mRNA Therapy competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, mRNA Therapy sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the mRNA Therapy sales, revenue and market share for each player covered in this report.
The major players covered in mRNA Therapy are:
Moderna
Arcturus Therapeutics Holdings Inc.
BioNTech
Pfizer
CureVac
Astrazeneca
Among other players domestic and global, mRNA Therapy market share data is available for global, North America, Europe, Asia-Pacific, Middle East & Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
1 mRNA Therapy Market Overview
1.1 Product Overview and Scope of mRNA Therapy
1.2 Classification of mRNA Therapy by Type
1.2.1 Global mRNA Therapy Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global mRNA Therapy Revenue Market Share by Type in 2019
1.2.3 Vaccine
1.2.4 Drugs
1.3 Global mRNA Therapy Market by Application
1.3.1 Overview: Global mRNA Therapy Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 mRNA Targeted Delivery in vivo
1.3.3 Genetically Modified T cells
1.3.4 Transforming Nanoparticles to Develop Immunotherapy for Cancer
1.3.5 Small Molecule Drugs Discovery
1.4 Global mRNA Therapy Market by Regions
1.4.1 Global mRNA Therapy Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of mRNA Therapy (2015-2025)
1.4.3 North America (USA, Canada and Mexico) mRNA Therapy Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) mRNA Therapy Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) mRNA Therapy Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) mRNA Therapy Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) mRNA Therapy Status and Prospect (2015-2025)
1.5 COVID-19 Outbreak: mRNA Therapy Industry Impact
1.5.1 COVID-19 Potential Implications for the mRNA Therapy
1.5.1.1 Scenario One: Very Optimistic: COVID-19 has No Influence on mRNA Therapy
1.5.1.2 Scenario Two: Optimistic: COVID-19 Will Be Under Control by the End of April
1.5.1.3 Scenario Three: Gloomy: COVID-19 Will Be Under Control Between Q3 and Q4
1.5.1.4 Scenario Four: Most Likely: COVID-19 Will Be Under Control by the End of Q2
1.5.2 Opportunity Analysis in Covid-19 Crisis
1.5.3 Market Risk and Restraints
1.5.4 Market Driving Force
2 Company Profiles
2.1 Moderna
2.1.1 Moderna Details
2.1.2 Moderna Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Moderna SWOT Analysis
2.1.4 Moderna Product and Services
2.1.5 Moderna mRNA Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.2 Arcturus Therapeutics Holdings Inc.
2.2.1 Arcturus Therapeutics Holdings Inc. Details
2.2.2 Arcturus Therapeutics Holdings Inc. Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Arcturus Therapeutics Holdings Inc. SWOT Analysis
2.2.4 Arcturus Therapeutics Holdings Inc. Product and Services
2.2.5 Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.3 BioNTech
2.3.1 BioNTech Details
2.3.2 BioNTech Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 BioNTech SWOT Analysis
2.3.4 BioNTech Product and Services
2.3.5 BioNTech mRNA Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.4 Pfizer
2.4.1 Pfizer Details
2.4.2 Pfizer Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Pfizer SWOT Analysis
2.4.4 Pfizer Product and Services
2.4.5 Pfizer mRNA Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.5 CureVac
2.5.1 CureVac Details
2.5.2 CureVac Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 CureVac SWOT Analysis
2.5.4 CureVac Product and Services
2.5.5 CureVac mRNA Therapy Revenue, Gross Margin and Market Share (2018-2019)
2.6 Astrazeneca
2.6.1 Astrazeneca Details
2.6.2 Astrazeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Astrazeneca SWOT Analysis
2.6.4 Astrazeneca Product and Services
2.6.5 Astrazeneca mRNA Therapy Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global mRNA Therapy Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 mRNA Therapy Players Market Share
3.2.2 Top 10 mRNA Therapy Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global mRNA Therapy Revenue and Market Share by Regions
4.2 North America mRNA Therapy Revenue and Growth Rate (2015-2020)
4.3 Europe mRNA Therapy Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific mRNA Therapy Revenue and Growth Rate (2015-2020)
4.5 South America mRNA Therapy Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa mRNA Therapy Revenue and Growth Rate (2015-2020)
5 North America mRNA Therapy Revenue by Countries
5.1 North America mRNA Therapy Revenue by Countries (2015-2020)
5.2 USA mRNA Therapy Revenue and Growth Rate (2015-2020)
5.3 Canada mRNA Therapy Revenue and Growth Rate (2015-2020)
5.4 Mexico mRNA Therapy Revenue and Growth Rate (2015-2020)
6 Europe mRNA Therapy Revenue by Countries
6.1 Europe mRNA Therapy Revenue by Countries (2015-2020)
6.2 Germany mRNA Therapy Revenue and Growth Rate (2015-2020)
6.3 UK mRNA Therapy Revenue and Growth Rate (2015-2020)
6.4 France mRNA Therapy Revenue and Growth Rate (2015-2020)
6.5 Russia mRNA Therapy Revenue and Growth Rate (2015-2020)
6.6 Italy mRNA Therapy Revenue and Growth Rate (2015-2020)
7 Asia-Pacific mRNA Therapy Revenue by Countries
7.1 Asia-Pacific mRNA Therapy Revenue by Countries (2015-2020)
7.2 China mRNA Therapy Revenue and Growth Rate (2015-2020)
7.3 Japan mRNA Therapy Revenue and Growth Rate (2015-2020)
7.4 Korea mRNA Therapy Revenue and Growth Rate (2015-2020)
7.5 India mRNA Therapy Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia mRNA Therapy Revenue and Growth Rate (2015-2020)
8 South America mRNA Therapy Revenue by Countries
8.1 South America mRNA Therapy Revenue by Countries (2015-2020)
8.2 Brazil mRNA Therapy Revenue and Growth Rate (2015-2020)
8.3 Argentina mRNA Therapy Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue mRNA Therapy by Countries
9.1 Middle East & Africa mRNA Therapy Revenue by Countries (2015-2020)
9.2 Saudi Arabia mRNA Therapy Revenue and Growth Rate (2015-2020)
9.3 UAE mRNA Therapy Revenue and Growth Rate (2015-2020)
9.4 Egypt mRNA Therapy Revenue and Growth Rate (2015-2020)
9.5 South Africa mRNA Therapy Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global mRNA Therapy Revenue and Market Share by Type (2015-2020)
10.2 Global mRNA Therapy Market Forecast by Type (2019-2024)
10.3 Vaccine Revenue Growth Rate (2015-2025)
10.4 Drugs Revenue Growth Rate (2015-2025)
11 Global mRNA Therapy Market Segment by Application
11.1 Global mRNA Therapy Revenue Market Share by Application (2015-2020)
11.2 mRNA Therapy Market Forecast by Application (2019-2024)
11.3 mRNA Targeted Delivery in vivo Revenue Growth (2015-2020)
11.4 Genetically Modified T cells Revenue Growth (2015-2020)
11.5 Transforming Nanoparticles to Develop Immunotherapy for Cancer Revenue Growth (2015-2020)
11.6 Small Molecule Drugs Discovery Revenue Growth (2015-2020)
12 Global mRNA Therapy Market Size Forecast (2021-2025)
12.1 Global mRNA Therapy Market Size Forecast (2021-2025)
12.2 Global mRNA Therapy Market Forecast by Regions (2021-2025)
12.3 North America mRNA Therapy Revenue Market Forecast (2021-2025)
12.4 Europe mRNA Therapy Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific mRNA Therapy Revenue Market Forecast (2021-2025)
12.6 South America mRNA Therapy Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa mRNA Therapy Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global mRNA Therapy Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of mRNA Therapy by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global mRNA Therapy Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market mRNA Therapy Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Global mRNA Therapy Market Size and Growth Estimation in Various Scenarios in 2020
Table 6. Moderna Corporate Information, Location and Competitors
Table 7. Moderna mRNA Therapy Major Business
Table 8. Moderna mRNA Therapy Total Revenue (USD Million) (2017-2018)
Table 9. Moderna SWOT Analysis
Table 10. Moderna mRNA Therapy Product and Solutions
Table 11. Moderna mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 12. Arcturus Therapeutics Holdings Inc. Corporate Information, Location and Competitors
Table 13. Arcturus Therapeutics Holdings Inc. mRNA Therapy Major Business
Table 14. Arcturus Therapeutics Holdings Inc. mRNA Therapy Total Revenue (USD Million) (2018-2019)
Table 15. Arcturus Therapeutics Holdings Inc. SWOT Analysis
Table 16. Arcturus Therapeutics Holdings Inc. mRNA Therapy Product and Solutions
Table 17. Arcturus Therapeutics Holdings Inc. mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 18. BioNTech Corporate Information, Location and Competitors
Table 19. BioNTech mRNA Therapy Major Business
Table 20. BioNTech mRNA Therapy Total Revenue (USD Million) (2017-2018)
Table 21. BioNTech SWOT Analysis
Table 22. BioNTech mRNA Therapy Product and Solutions
Table 23. BioNTech mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 24. Pfizer Corporate Information, Location and Competitors
Table 25. Pfizer mRNA Therapy Major Business
Table 26. Pfizer mRNA Therapy Total Revenue (USD Million) (2017-2018)
Table 27. Pfizer SWOT Analysis
Table 28. Pfizer mRNA Therapy Product and Solutions
Table 29. Pfizer mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 30. CureVac Corporate Information, Location and Competitors
Table 31. CureVac mRNA Therapy Major Business
Table 32. CureVac mRNA Therapy Total Revenue (USD Million) (2017-2018)
Table 33. CureVac SWOT Analysis
Table 34. CureVac mRNA Therapy Product and Solutions
Table 35. CureVac mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 36. Astrazeneca Corporate Information, Location and Competitors
Table 37. Astrazeneca mRNA Therapy Major Business
Table 38. Astrazeneca mRNA Therapy Total Revenue (USD Million) (2017-2018)
Table 39. Astrazeneca SWOT Analysis
Table 40. Astrazeneca mRNA Therapy Product and Solutions
Table 41. Astrazeneca mRNA Therapy Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 42. Global mRNA Therapy Revenue (Million USD) by Players (2015-2020)
Table 43. Global mRNA Therapy Revenue Share by Players (2015-2020)
Table 44. Global mRNA Therapy Revenue (Million USD) by Regions (2015-2020)
Table 45. Global mRNA Therapy Revenue Market Share by Regions (2015-2020)
Table 46. North America mRNA Therapy Revenue by Countries (2015-2020)
Table 47. North America mRNA Therapy Revenue Market Share by Countries (2015-2020)
Table 48. Europe mRNA Therapy Revenue (Million USD) by Countries (2015-2020)
Table 49. Asia-Pacific mRNA Therapy Revenue (Million USD) by Countries (2015-2020)
Table 50. South America mRNA Therapy Revenue by Countries (2015-2020)
Table 51. South America mRNA Therapy Revenue Market Share by Countries (2015-2020)
Table 52. Middle East and Africa mRNA Therapy Revenue (Million USD) by Countries (2015-2020)
Table 53. Middle East and Africa mRNA Therapy Revenue Market Share by Countries (2015-2020)
Table 54. Global mRNA Therapy Revenue (Million USD) by Type (2015-2020)
Table 55. Global mRNA Therapy Revenue Share by Type (2015-2020)
Table 56. Global mRNA Therapy Revenue Forecast by Type (2021-2025)
Table 57. Global mRNA Therapy Revenue by Application (2015-2020)
Table 58. Global mRNA Therapy Revenue Share by Application (2015-2020)
Table 59. Global mRNA Therapy Revenue Forecast by Application (2021-2025)
Table 60. Global mRNA Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. mRNA Therapy Picture
Figure 2. Global mRNA Therapy Revenue Market Share by Type in 2019
Figure 3. Vaccine Picture
Figure 4. Drugs Picture
Figure 5. mRNA Therapy Revenue Market Share by Application in 2019
Figure 6. mRNA Targeted Delivery in vivo Picture
Figure 7. Genetically Modified T cells Picture
Figure 8. Transforming Nanoparticles to Develop Immunotherapy for Cancer Picture
Figure 9. Small Molecule Drugs Discovery Picture
Figure 10. Global mRNA Therapy Revenue (USD Million) and Growth Rate (2015-2025)
Figure 11. North America mRNA Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Europe mRNA Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. Asia-Pacific mRNA Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. South America mRNA Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Middle East and Africa mRNA Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global mRNA Therapy Revenue (Million USD) and Growth Rate (2015-2025)
Figure 17. Global mRNA Therapy Revenue Share by Players in 2019
Figure 18. Global Top 5 Players mRNA Therapy Revenue Market Share in 2019
Figure 19. Global Top 10 Players mRNA Therapy Revenue Market Share in 2019
Figure 20. Key Players Market Share Trend
Figure 21. Global mRNA Therapy Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 22. Global mRNA Therapy Revenue Market Share by Regions (2015-2020)
Figure 23. Global mRNA Therapy Revenue Market Share by Regions in 2018
Figure 24. North America mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 25. Europe mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 26. Asia-Pacific mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 27. South America mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 28. Middle East and Africa mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 29. North America mRNA Therapy Revenue Market Share by Countries (2015-2020)
Figure 30. North America mRNA Therapy Revenue Market Share by Countries in 2019
Figure 31. USA mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 32. Canada mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 33. Mexico mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 34. Europe mRNA Therapy Revenue Market Share by Countries (2015-2020)
Figure 35. Europe mRNA Therapy Revenue Market Share by Countries in 2019
Figure 36. Germany mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 37. UK mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 38. France mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 39. Russia mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 40. Italy mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 41. Asia-Pacific mRNA Therapy Revenue Market Share by Countries (2015-2020)
Figure 42. Asia-Pacific mRNA Therapy Revenue Market Share by Countries in 2019
Figure 43. China mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 44. Japan mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 45. Korea mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 46. India mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 47. Southeast Asia mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 48. South America mRNA Therapy Revenue Market Share by Countries (2015-2020)
Figure 49. South America mRNA Therapy Revenue Market Share by Countries in 2019
Figure 50. Brazil mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 51. Argentina mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 52. Middle East and Africa mRNA Therapy Revenue Market Share by Countries (2015-2020)
Figure 53. Middle East and Africa mRNA Therapy Revenue Market Share by Countries in 2019
Figure 54. Saudi Arabia mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 55. UAE mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 56. Egypt mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 57. South Africa mRNA Therapy Revenue and Growth Rate (2015-2020)
Figure 58. Global mRNA Therapy Revenue Share by Type (2015-2020)
Figure 59. Global mRNA Therapy Revenue Share by Type in 2019
Figure 60. Global mRNA Therapy Market Share Forecast by Type (2021-2025)
Figure 61. Global Vaccine Revenue Growth Rate (2015-2020)
Figure 62. Global Drugs Revenue Growth Rate (2015-2020)
Figure 63. Global mRNA Therapy Revenue Share by Application (2015-2020)
Figure 64. Global mRNA Therapy Revenue Share by Application in 2019
Figure 65. Global mRNA Therapy Market Share Forecast by Application (2021-2025)
Figure 66. Global mRNA Targeted Delivery in vivo Revenue Growth Rate (2015-2020)
Figure 67. Global Genetically Modified T cells Revenue Growth Rate (2015-2020)
Figure 68. Global Transforming Nanoparticles to Develop Immunotherapy for Cancer Revenue Growth Rate (2015-2020)
Figure 69. Global Small Molecule Drugs Discovery Revenue Growth Rate (2015-2020)
Figure 70. Global mRNA Therapy Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 71. Global mRNA Therapy Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 72. Global mRNA Therapy Revenue Market Share Forecast by Regions (2021-2025)
Figure 73. North America mRNA Therapy Revenue Market Forecast (2021-2025)
Figure 74. Europe mRNA Therapy Revenue Market Forecast (2021-2025)
Figure 75. Asia-Pacific mRNA Therapy Revenue Market Forecast (2021-2025)
Figure 76. South America mRNA Therapy Revenue Market Forecast (2021-2025)
Figure 77. Middle East and Africa mRNA Therapy Revenue Market Forecast (2021-2025)
Figure 78. Sales Channel: Direct Channel vs Indirect Channel
mRNAワクチンの世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Vaccines market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade r…- mRNA癌ワクチン及び治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The mRNA Cancer Vaccines and Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value cha…
- 注射型標的療法の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Injectable Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiz…
- 小分子標的治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Small Molecule Targeted Therapy market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain opt…
- 心臓再同期療法（CRT）の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Cardiac Resynchronization Therapy (CRT) market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.3% in the forecast period of 2020 to 2025 and will expected to reach USD 5790.2 million by 2025, from USD 4895.2 million in 2019. …